Showing results (51-60 of 73) with videos related to
Sort By:
Pageof 8
Journal of Market Access & Health Policy|July 5, 2023
Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatmentsAndrea Aiello, Elisa Elena Mariano, Mariangela Prada, et al.Journal of Market Access & Health Policy|July 24, 2026
The EU-Joint Clinical Assessment Guidance Documents Fail to Address the Significance of Systematic Literature Reviews and Deviate from the State of the ArtBeata Smela, Mondher Toumi, Samuel Aballéa, et al.Clinical and Experimental Rheumatology|June 24, 2020
Impact of one-year treatment with biotechnological drugs on work ability in patients with rheumatoid arthritis in Italy: a prospective real-life studyMaria Manara, Roberto Caporali, Claudia Lomater, et al.Journal of Market Access & Health Policy|June 20, 2018
Approaches to manage 'affordability' of high budget impact medicines in key EU countriesMathias Flume, Marc Bardou, Stefano Capri, et al.European Journal of Public Health|October 17, 2014
Economic impact of adult obesity on health systems: a systematic reviewMaria Lucia Specchia, Maria Assunta Veneziano, Chiara Cadeddu, et al.Journal of Market Access & Health Policy|May 27, 2026
EU-HTA-Why Do Words Matter?Mondher Toumi, Bruno Falissard, Steven Simoens, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysisJosephine A Mauskopf, Sean D Sullivan, Lieven Annemans, et al.Atherosclerosis|May 20, 2011
Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databasesGiovanni Corrao, Lorenza Scotti, Antonella Zambon, et al.Lung Cancer (Amsterdam, Netherlands)|August 24, 2010
Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancerMark Nuijten, David F Heigener, Helge G Bischoff, et al.Vaccine|November 26, 2008
Comparison of detailed and succinct cohort modelling approaches in a multi-regional evaluation of cervical cancer vaccinationDonna Debicki, Nicole Ferko, Nadia Demarteau, et al.Pageof 8